BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28516636)

  • 1. Sci-Sat AM: Brachy - 08: MRI-guided planning and maximum achievable HR-CTV doses in cervix brachytherapy.
    Menon G; Sloboda R; Ghosh S; Dundas G; Pearcey R; Huang F
    Med Phys; 2012 Jul; 39(7Part4):4646. PubMed ID: 28516636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
    Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma.
    De Brabandere M; Mousa AG; Nulens A; Swinnen A; Van Limbergen E
    Radiother Oncol; 2008 Aug; 88(2):217-26. PubMed ID: 18037524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of two dose optimization methods for image-guided, highly-conformal, tandem and ovoids cervix brachytherapy planning.
    Ren J; Menon G; Sloboda R
    Phys Med Biol; 2013 Apr; 58(7):2045-58. PubMed ID: 23459004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer.
    Tanderup K; Nielsen SK; Nyvang GB; Pedersen EM; Røhl L; Aagaard T; Fokdal L; Lindegaard JC
    Radiother Oncol; 2010 Feb; 94(2):173-80. PubMed ID: 20138380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
    Paton AM; Chalmers KE; Coomber H; Cameron AL
    Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SU-E-T-430: Evaluation of Inverse Optimization in Brachytherapy for Locally Advanced Cervix Cancer.
    Liao Y; Dandekar V; Chu J; Turian J; Kiel K
    Med Phys; 2012 Jun; 39(6Part16):3803. PubMed ID: 28517217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.
    Anderson JW; Xia J; Flynn RT; Modrick JM; Bhatia SK; Jacobson GM; Kim Y
    J Contemp Brachytherapy; 2013 Jun; 5(2):101-9. PubMed ID: 23878555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
    Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
    Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer.
    Takenaka T; Yoshida K; Tachiiri S; Yamazaki H; Aramoto K; Furuya S; Yoshida M; Ban C; Tanaka E; Honda K
    J Radiat Res; 2012 Sep; 53(5):791-7. PubMed ID: 22843369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
    Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
    Morcos M; Antaki M; Viswanathan AN; Enger SA
    Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
    Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
    Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
    Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of CT-based volumetric dosimetry with traditional prescription points in the treatment of cervical cancer with PDR brachytherapy.
    Lowrey N; Nilsson S; Moutrie Z; Chan P; Cheuk R
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):640-5. PubMed ID: 26223554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.